Tandem Diabetes Care

233 articles about Tandem Diabetes Care

• Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S.

  12/6/2023

  Tandem Diabetes Care, Inc. today announced the launch of updated t:slim X2™ insulin pump software with Dexcom G7 Continuous Glucose Monitoring (CGM) integration in the United States.

• Tandem Diabetes Care Announces Upcoming November 2023 Conference Presentations

  11/6/2023

  Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the following investor conferences.

• Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer

  11/1/2023

  Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced the appointment of Mark Novara as Executive Vice President and Chief Commercial Officer, effective November 13, 2023.

• Tandem Diabetes Care Announces Third Quarter 2023 Financial Results

  11/1/2023

  Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company, reported its financial results for the quarter ended September 30, 2023 and updated its financial guidance for the year ending December 31, 2023.

• Tandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023

  10/10/2023

  Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2023 results after the financial markets close on Wednesday, November 1, 2023.

• Tandem Diabetes Care Announces Upcoming September 2023 Conference Presentations

  8/24/2023

  Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the following investor conferences.

• Tandem Diabetes Care Announces Technology Access Program to Provide Customers with Purchase Pathway to the Tandem Mobi System

  8/3/2023

  Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced a limited time offer for its Tandem Choice technology access program.

• Tandem Diabetes Care Announces Second Quarter 2023 Financial Results and Updated Full Year 2023 Financial Guidance

  8/3/2023

  Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2023 and updated its financial guidance for the year ending December 31, 2023.

• Tandem Diabetes Care to Present at the UBS MedTech, Tools and Genomics Summit 2023

  8/1/2023

  Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the UBS MedTech, Tools and Genomics Summit 2023 on Wednesday, August 16, 2023 at 2:00pm Eastern Time.

• Tandem Diabetes Care to Announce Second Quarter 2023 Financial Results on August 3, 2023

  7/10/2023

  Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, plans to release its second quarter 2023 results after the financial markets close on Thursday, August 3, 2023.

• Tandem Diabetes Care to Present at the 2023 Jefferies Healthcare Conference

  5/24/2023

  Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the Jefferies Healthcare Conference on Thursday, June 8, 2023 at 1:30pm Eastern Time.

• Tandem Diabetes Care Announces First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Guidance

  5/3/2023

  Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2023 and reaffirmed its financial guidance for the year ending December 31, 2023.

• Tandem Diabetes Care to Present at the BofA Securities 2023 Health Care Conference

  4/20/2023

  Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the BofA Securities 2023 Health Care Conference on Wednesday, May 10, 2023 at 4:40pm Eastern Time.

• Tandem Diabetes Care Announces Control-IQ Technology Meta-analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 Diabetes

  4/17/2023

  Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by Diabetes Technology & Therapeutics of a meta-analysis of three randomized controlled trials of its Control-IQ advanced hybrid closed-loop technology.

• Tandem Diabetes Care to Announce First Quarter 2023 Financial Results on May 3, 2023

  4/11/2023

  Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2023 results after the financial markets close on Wednesday, May 3, 2023.

• Tandem Diabetes Care Announces NEJM Publication of Study Demonstrating Increased Time in Range in Young Children with Type 1 Diabetes Using the t:slim X2 Insulin Pump with Control-IQ Technology

  3/15/2023

  Tandem Diabetes Care, Inc. announced publication of results from the Pediatric Artificial Pancreas Clinical Trial by the New England Journal of Medicine showing an approximate 3-hour per day increase in time in range* in children ages 2-5 years old using the t:slim X2 insulin pump with Control-IQ advanced hybrid closed-loop technology** compared to those on a standard insulin pump or multiple daily injections.

• Tandem Diabetes Care Appoints New Chair of Board of Directors

  2/22/2023

  Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced the appointment of Rebecca Robertson as Chair of its Board of Directors.

• Tandem Diabetes Care Announces Fourth Quarter 2022 Financial Results and Full Year 2023 Financial Guidance

  2/22/2023

  Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2022 and provided its financial guidance for the year ending December 31, 2023.

• Tandem Diabetes Care Announces Upcoming March 2023 Conference Presentations

  2/15/2023

  Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the following investor conferences.

• Tandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF Medical

  1/23/2023

  Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company, announced the completion of its previously announced acquisition of AMF Medical SA, the privately held Swiss developer of the Sigi™ Patch Pump.